GL1X · GenesisL1 explorer

MolNFT v1 · #74399 · protein

Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase

3OVN · Pol polyprotein: “Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase”. X-ray diffraction, 5 ligands (MPV, GLC, FRU), 5 pockets (best druggability 0.53). MolNFT v1 #74399 on GenesisL1: 3D…

PDB
3OVN
Type
protein
Length
284 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pol polyprotein
UniProt
Q72498
Ligands
MPV, GLC, FRU, CD, SO4
Pockets
5 · best druggability 0.53

Structure

x-ray diffraction · 2 distinct chains · 48% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APol polyproteinprotein14347% helix, 25% strandQ72498
BPol polyproteinprotein14149% helix, 23% strandQ72498

Ligands and binding sites

  • MPV · 1-methyl-3-(thiophen-2-yl)-1H-pyrazol-5-amine · ligand · 2 copies · chains A, B
  • GLC · alpha-D-glucopyranose · sugar · chains A, B
  • FRU · beta-D-fructofuranose · sugar · chains A, B
  • CD · Cadmium ion · metal · 4 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11520.530.8020GLC, FRU
2760.470.8219MPV
3910.450.8017MPV
4980.400.7616empty
5620.380.7915empty

Interfaces

1 interface between chains.

  • A–B · 1539 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 3OVN · Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.